TGFB1 and neoplasm: Moreover, the complexity of the TME, with its multiple immunosuppressive cells (e.g., tumor-associated macrophages and regulatory T cells) and inhibitory cytokines (e.g., TGF-β), poses a significant challenge for immunotherapy [69].